Bessemer Group Inc Agios Pharmaceuticals, Inc. Transaction History
Bessemer Group Inc
- $55.8 Billion
- Q1 2025
A detailed history of Bessemer Group Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 110 shares of AGIO stock, worth $3,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 120
8.33%
Holding current value
$3,258
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AGIO
# of Institutions
242Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$168 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$167 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$144 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$104 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$71.8 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.62B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...